ProtocolsBack To Search Instructions
8 protocol(s) meet the specified criteria
Disease Site: Brain and Ner
Protocol No.TitleStatus
1224GCCPhase II Trial of Low-Dose Whole Brain Radiotherapy with Concurrent Temozolomide and Adjuvant Temozolomide in Patients with Newly-Diagnosed Glioblastoma MultiformeOpen
1344GCCPILOT STUDY OF COMBINED OPTUNE, BEVACIZUMAB, AND HYPOFRACTIONATED STEREOTACTIC IRRADIATION FOR BEVACIZUMAB-NAIIVE, RECURRENT GLIOBLASTOMA Open
1455GCCAn Umbrella Protocol for Collection of Blood Samples from Patients Undergoing Craniotomy or Stereotactic Brain Biopsy, to be used in Laboratory ResearchOpen
1532GCCPhase I Study of C6 Ceramide Nanoliposome in Patients with Advanced Solid TumorsOpen
16114GCCMETIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC).Open
1614GCC Phase 1 Trial to Determine the Recommended Phase 2 Dose (RP2D) of VX-970 When Combined with Whole Brain Radiotherapy (WBRT) in Patients with Brain Metastases from Non-Small Cell Lung Cancer (NSCLC)Open
1837GCCCA DOUBLE BLIND, PLACEBO CONTROLLED DOSE RANGE FINDING STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF TEMPOL FOR THE REDUCTION OF SEVERE MUCOSITIS IN HEAD AND NECK CANCER PATIENTS UNDERGOING RADIOTHERAPY OR COMBINED RADIO- AND CHEMOTHERAPYOpen
NRG-BN001RANDOMIZED PHASE II TRIAL OF HYPOFRACTIONATED DOSE-ESCALATED PHOTON IMRT OR PROTON BEAM THERAPY VERSUS CONVENTIONAL PHOTON IRRADIATION WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAOpen